The Patent Finder

Ignova GmbH

Also on record
Records under this name other than patents Ignova GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Ignova GmbH

PatentTitleStatus Expires Confidence
US 10,261,095Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,913,904Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
Formerly held
Lapsed on the fee record
Ended Mar 13, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 13, 2026From the USPTO record
US 9,801,938Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists
Formerly held
Lapsed on the fee record
Ended Oct 31, 2025 · From the USPTO record
Lapsed on the fee recordEnded Oct 31, 2025From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited